Milpath en es it fr

Milpath Brand names, Milpath Analogs

Milpath Brand Names Mixture

  • No information avaliable

Milpath Chemical_Formula


Milpath RX_link

No information avaliable

Milpath fda sheet

Milpath msds (material safety sheet)

Milpath Synthesis Reference

No information avaliable

Milpath Molecular Weight

309.469 g/mol

Milpath Melting Point

< 25 oC

Milpath H2O Solubility

Soluble as HCl salt

Milpath State


Milpath LogP


Milpath Dosage Forms

Tablets (oral, 1 mg)

Milpath Indication

Used for the symptomatic treatment of parkinsonism.

Milpath Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Milpath Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Milpath side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Milpath Patient Information

Milpath Organisms Affected

Humans and other mammals